| Systematic (IUPAC) name | |
|---|---|
| 5-nitroquinolin-8-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 4008-48-4 |
| ATC code | J01XX07 |
| PubChem | CID 19910 |
| DrugBank | DB01422 |
| ChemSpider | 18756 |
| UNII | A8M33244M6 |
| KEGG | D07245 |
| ChEMBL | CHEMBL1454910 |
| Chemical data | |
| Formula | C9H6N2O3 |
| Mol. mass | 190.156 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Nitroxoline is an antibiotic.[1]
It was recently discovered that nitroxoline has antiangiogenic properties, which could make it useful as an anti-cancer drug. [2]
|
|||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)